乾癬性関節炎治療の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Psoriatic Arthritis Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00558 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、乾癬性関節炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。乾癬性関節炎治療の種類別市場規模（非ステロイド系抗炎症薬、疾患修飾抗リウマチ薬、生物製剤、酵素阻害剤）、用途別市場規模（病院、クリニック、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Amgen、Abbott Laboratories、Bayer、Janssen Biotech、Novartis、AbbVie、Bristol-Myers Squibb、Sanofi、UCB ・地域別グローバル市場分析 2015年-2020年 ・乾癬性関節炎治療の北米市場（アメリカ、カナダ、メキシコ） ・乾癬性関節炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・乾癬性関節炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・乾癬性関節炎治療の南米市場（ブラジル、アルゼンチン） ・乾癬性関節炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非ステロイド系抗炎症薬、疾患修飾抗リウマチ薬、生物製剤、酵素阻害剤 ・用途別分析：病院、クリニック、研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Psoriatic Arthritis Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.6% in the forecast period of 2020 to 2025 and will expected to reach USD 9151.4 million by 2025, from USD 6585.3 million in 2019.

The Psoriatic Arthritis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Psoriatic Arthritis Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Psoriatic Arthritis Therapeutics market has been segmented into:
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor

By Application, Psoriatic Arthritis Therapeutics has been segmented into:
Hospitals
Clinics
Research Labs

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Psoriatic Arthritis Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Psoriatic Arthritis Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Psoriatic Arthritis Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Psoriatic Arthritis Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Psoriatic Arthritis Therapeutics Market Share Analysis
Psoriatic Arthritis Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Psoriatic Arthritis Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Psoriatic Arthritis Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Psoriatic Arthritis Therapeutics are:
Pfizer
Amgen
Abbott Laboratories
Bayer
Janssen Biotech
Novartis
AbbVie
Bristol-Myers Squibb
Sanofi
UCB

レポート目次

---

Table of Contents

1 Psoriatic Arthritis Therapeutics Market Overview
1.1 Product Overview and Scope of Psoriatic Arthritis Therapeutics
1.2 Classification of Psoriatic Arthritis Therapeutics by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type in 2019
1.2.3 Nonsteroidal Anti-Inflammatory Drug
1.2.4 Disease-Modifying Antirheumatic Drug
1.2.5 Biologic Drug
1.2.6 Enzyme Inhibitor
1.3 Global Psoriatic Arthritis Therapeutics Market by Application
1.3.1 Overview: Global Psoriatic Arthritis Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.4 Global Psoriatic Arthritis Therapeutics Market by Regions
1.4.1 Global Psoriatic Arthritis Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Psoriatic Arthritis Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Psoriatic Arthritis Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Psoriatic Arthritis Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psoriatic Arthritis Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Psoriatic Arthritis Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psoriatic Arthritis Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories SWOT Analysis
2.3.4 Abbott Laboratories Product and Services
2.3.5 Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Janssen Biotech
2.5.1 Janssen Biotech Details
2.5.2 Janssen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Janssen Biotech SWOT Analysis
2.5.4 Janssen Biotech Product and Services
2.5.5 Janssen Biotech Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AbbVie SWOT Analysis
2.7.4 AbbVie Product and Services
2.7.5 AbbVie Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb SWOT Analysis
2.8.4 Bristol-Myers Squibb Product and Services
2.8.5 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 UCB
2.10.1 UCB Details
2.10.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 UCB SWOT Analysis
2.10.4 UCB Product and Services
2.10.5 UCB Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Psoriatic Arthritis Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Psoriatic Arthritis Therapeutics Players Market Share
3.2.2 Top 10 Psoriatic Arthritis Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Psoriatic Arthritis Therapeutics Revenue and Market Share by Regions
4.2 North America Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Psoriatic Arthritis Therapeutics Revenue by Countries
5.1 North America Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
5.2 USA Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Psoriatic Arthritis Therapeutics Revenue by Countries
6.1 Europe Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Countries
7.1 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
7.2 China Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Psoriatic Arthritis Therapeutics Revenue by Countries
8.1 South America Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Psoriatic Arthritis Therapeutics by Countries
9.1 Middle East & Africa Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Psoriatic Arthritis Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Psoriatic Arthritis Therapeutics Market Forecast by Type (2019-2024)
10.3 Nonsteroidal Anti-Inflammatory Drug Revenue Growth Rate (2015-2025)
10.4 Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2015-2025)
10.5 Biologic Drug Revenue Growth Rate (2015-2025)
10.6 Enzyme Inhibitor Revenue Growth Rate (2015-2025)
11 Global Psoriatic Arthritis Therapeutics Market Segment by Application
11.1 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Psoriatic Arthritis Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Research Labs Revenue Growth (2015-2020)
12 Global Psoriatic Arthritis Therapeutics Market Size Forecast (2021-2025)
12.1 Global Psoriatic Arthritis Therapeutics Market Size Forecast (2021-2025)
12.2 Global Psoriatic Arthritis Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Psoriatic Arthritis Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Psoriatic Arthritis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Psoriatic Arthritis Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Psoriatic Arthritis Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Psoriatic Arthritis Therapeutics Major Business
Table 7. Pfizer Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Psoriatic Arthritis Therapeutics Product and Solutions
Table 10. Pfizer Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Amgen Corporate Information, Location and Competitors
Table 12. Amgen Psoriatic Arthritis Therapeutics Major Business
Table 13. Amgen Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Amgen SWOT Analysis
Table 15. Amgen Psoriatic Arthritis Therapeutics Product and Solutions
Table 16. Amgen Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Laboratories Corporate Information, Location and Competitors
Table 18. Abbott Laboratories Psoriatic Arthritis Therapeutics Major Business
Table 19. Abbott Laboratories Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Abbott Laboratories SWOT Analysis
Table 21. Abbott Laboratories Psoriatic Arthritis Therapeutics Product and Solutions
Table 22. Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Corporate Information, Location and Competitors
Table 24. Bayer Psoriatic Arthritis Therapeutics Major Business
Table 25. Bayer Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Bayer SWOT Analysis
Table 27. Bayer Psoriatic Arthritis Therapeutics Product and Solutions
Table 28. Bayer Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Janssen Biotech Corporate Information, Location and Competitors
Table 30. Janssen Biotech Psoriatic Arthritis Therapeutics Major Business
Table 31. Janssen Biotech Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Janssen Biotech SWOT Analysis
Table 33. Janssen Biotech Psoriatic Arthritis Therapeutics Product and Solutions
Table 34. Janssen Biotech Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Psoriatic Arthritis Therapeutics Major Business
Table 37. Novartis Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Psoriatic Arthritis Therapeutics Product and Solutions
Table 40. Novartis Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. AbbVie Corporate Information, Location and Competitors
Table 42. AbbVie Psoriatic Arthritis Therapeutics Major Business
Table 43. AbbVie Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. AbbVie SWOT Analysis
Table 45. AbbVie Psoriatic Arthritis Therapeutics Product and Solutions
Table 46. AbbVie Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 48. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Major Business
Table 49. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Bristol-Myers Squibb SWOT Analysis
Table 51. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product and Solutions
Table 52. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Sanofi Corporate Information, Location and Competitors
Table 54. Sanofi Psoriatic Arthritis Therapeutics Major Business
Table 55. Sanofi Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Sanofi SWOT Analysis
Table 57. Sanofi Psoriatic Arthritis Therapeutics Product and Solutions
Table 58. Sanofi Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. UCB Corporate Information, Location and Competitors
Table 60. UCB Psoriatic Arthritis Therapeutics Major Business
Table 61. UCB Psoriatic Arthritis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. UCB SWOT Analysis
Table 63. UCB Psoriatic Arthritis Therapeutics Product and Solutions
Table 64. UCB Psoriatic Arthritis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Psoriatic Arthritis Therapeutics Revenue Share by Players (2015-2020)
Table 67. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Regions (2015-2020)
Table 69. North America Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
Table 70. North America Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Psoriatic Arthritis Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Psoriatic Arthritis Therapeutics Revenue by Countries (2015-2020)
Table 74. South America Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Psoriatic Arthritis Therapeutics Revenue Share by Type (2015-2020)
Table 79. Global Psoriatic Arthritis Therapeutics Revenue Forecast by Type (2021-2025)
Table 80. Global Psoriatic Arthritis Therapeutics Revenue by Application (2015-2020)
Table 81. Global Psoriatic Arthritis Therapeutics Revenue Share by Application (2015-2020)
Table 82. Global Psoriatic Arthritis Therapeutics Revenue Forecast by Application (2021-2025)
Table 83. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Psoriatic Arthritis Therapeutics Picture
Figure 2. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type in 2019
Figure 3. Nonsteroidal Anti-Inflammatory Drug Picture
Figure 4. Disease-Modifying Antirheumatic Drug Picture
Figure 5. Biologic Drug Picture
Figure 6. Enzyme Inhibitor Picture
Figure 7. Psoriatic Arthritis Therapeutics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Research Labs Picture
Figure 11. Global Psoriatic Arthritis Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Psoriatic Arthritis Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Psoriatic Arthritis Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Psoriatic Arthritis Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Psoriatic Arthritis Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Psoriatic Arthritis Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Psoriatic Arthritis Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Psoriatic Arthritis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Psoriatic Arthritis Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Psoriatic Arthritis Therapeutics Revenue Share by Type in 2019
Figure 61. Global Psoriatic Arthritis Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global Nonsteroidal Anti-Inflammatory Drug Revenue Growth Rate (2015-2020)
Figure 63. Global Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2015-2020)
Figure 64. Global Biologic Drug Revenue Growth Rate (2015-2020)
Figure 65. Global Enzyme Inhibitor Revenue Growth Rate (2015-2020)
Figure 66. Global Psoriatic Arthritis Therapeutics Revenue Share by Application (2015-2020)
Figure 67. Global Psoriatic Arthritis Therapeutics Revenue Share by Application in 2019
Figure 68. Global Psoriatic Arthritis Therapeutics Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Research Labs Revenue Growth Rate (2015-2020)
Figure 72. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Psoriatic Arthritis Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Psoriatic Arthritis Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Psoriatic Arthritis Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---